Standalone Allergan (AGN) Could Be Worth $300 - RBC

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. IBM
10. HOOD

Go back to Standalone Allergan (AGN) Could Be Worth $300 - RBC

Allergan Reiterates Strong Standalone Growth Profile and Strategy Following Termination of Pfizer Transaction

April 6, 2016 6:45 AM EDT

DUBLIN, April 6, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced that its merger agreement with Pfizer (NYSE: PFE) has been terminated by mutual agreement, effective today. In connection with the termination of the merger agreement, Pfizer has agreed to pay Allergan $150 million for reimbursement of expenses associated with the transaction.

Logo - http://photos.prnewswire.com/prnh/20150612/222796LOGO

Allergan reiterated its compelling standalone growth profile and strategy following the... More

Pfizer Announces Termination of Proposed Combination with Allergan

April 6, 2016 6:45 AM EDT

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced that the merger agreement between Pfizer and Allergan plc (NYSE: AGN) has been terminated by mutual agreement of the companies. The decision was driven by the actions announced by the U.S. Department of Treasury on April 4, 2016, which the companies concluded qualified as an Adverse Tax Law Change under the merger agreement.

Pfizer approached this transaction from a position of strength and viewed the potential combination as an accelerator of existing strategies, stated Ian Read, Chairman and Chief Executive... More